Good Profile of Efficacy/Tolerance of Bortezomib or Idelalisib in Waldenström Macroglobulinemia Associated with Acquired Von Willebrand Syndrome

Good Profile of Efficacy/Tolerance of Bortezomib or Idelalisib in Waldenström Macroglobulinemia Associated with Acquired Von Willebrand Syndrome

Mario Ojeda-Uribe,1 Valérie Rimelen,2 Cathérine Marzullo3 1Department of Hematology and Cellular Therapy Unit, Groupe Hospitalier Region Mulhouse-Sud-Alsace (GHRMSA), Mulhouse 68070, France; 2Laboratory of Molecular Biology CHRU Strasbourg, Strasbourg 67200, France; 3Laboratory...

Full description

Bibliographic Details
Main Authors: Ojeda-Uribe M, Rimelen V, Marzullo C
Format: Article
Language:English
Published: Dove Medical Press 2020-02-01
Series:Journal of Blood Medicine
Subjects:
waldenström macroglobulinemia
acquired von willebrand syndrome
bortezomib
idelalisib
proteasome inhibitors
von willebrand factor.
Online Access:https://www.dovepress.com/good-profile-of-efficacytolerance-of-bortezomib-or-idelalisib-in-walde-peer-reviewed-article-JBM

Internet

https://www.dovepress.com/good-profile-of-efficacytolerance-of-bortezomib-or-idelalisib-in-walde-peer-reviewed-article-JBM

Similar Items